Literature DB >> 33368243

Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis.

Jutta Huvila1,2, Jennifer Pors2, Emily F Thompson2, C Blake Gilks2.   

Abstract

Endometrial carcinoma (EC) is classified into a wide range of morphological variants; this list has expanded over the past decade with the inclusion of mesonephric-like and dedifferentiated carcinoma as EC variants in the fifth edition of the WHO Classification of Female Genital Tumours, and recognition that carcinosarcoma is a biphasic carcinoma rather than a sarcoma. Each EC variant has distinct molecular abnormalities, including TCGA-based molecular subtypes, allowing further subclassification and adding complexity. In contrast to this rapid progress in understanding EC, there are only two recognized EC precursor lesions: endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia (EAH/EIN) and serous intraepithelial carcinoma, a situation that has not changed for many years. Diagnosis of EC precursors is a cornerstone of surgical pathology practice, with early diagnosis contributing to the relatively favorable prognosis of EC. In this review we relate the precursor lesions to each of the EC morphological variants and molecular subtypes, discuss how successful early diagnosis is for each variant/molecular subtype and how it might be improved, and identify knowledge gaps where there is insufficient understanding of EC histogenesis.
© 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  atypical hyperplasia; endometrioid intraepithelial neoplasia; endometrial carcinoma; endometrium

Year:  2021        PMID: 33368243     DOI: 10.1002/path.5608

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  17 in total

1.  Value of serum p53, PKD1, and MAP2K4 in evaluating the condition and prognosis of endometrial carcinoma.

Authors:  Xiang Zhang; Yue Huang; Xuecheng Pang
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 2.  Histopathologic diagnosis of endometrial precancers: Updates and future directions.

Authors:  Hao Chen; Amanda L Strickland; Diego H Castrillon
Journal:  Semin Diagn Pathol       Date:  2021-12-10       Impact factor: 3.893

3.  Identification of risk factors for the prognosis of Chinese patients with endometrial carcinoma.

Authors:  Na Wang; Jun Zhang; Xiaomei Fan; Junying Ma; Jing He; Shan Kang; Jianxin Cheng; Jing Ma
Journal:  Medicine (Baltimore)       Date:  2021-09-24       Impact factor: 1.817

4.  Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors.

Authors:  Mitzi Aguilar; He Zhang; Musi Zhang; Brandi Cantarell; Subhransu S Sahoo; Hao-Dong Li; Ileana C Cuevas; Jayanthi Lea; David S Miller; Hao Chen; Wenxin Zheng; Jeffrey Gagan; Elena Lucas; Diego H Castrillon
Journal:  J Pathol       Date:  2021-03-09       Impact factor: 7.996

Review 5.  Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.

Authors:  Riccardo Di Fiore; Sherif Suleiman; Francesca Pentimalli; Sharon A O'Toole; John J O'Leary; Mark P Ward; Neil T Conlon; Maja Sabol; Petar Ozretić; Ayse Elif Erson-Bensan; Nicholas Reed; Antonio Giordano; C Simon Herrington; Jean Calleja-Agius
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

6.  Next-Generation Sequencing Reveals a Very Low Prevalence of Deleterious Mutations of Homologous Recombination Repair Genes and Homologous Recombination Deficiency in Ovarian Clear Cell Carcinoma.

Authors:  Hangqi Liu; Zhiwen Zhang; Longyun Chen; Junyi Pang; Huanwen Wu; Zhiyong Liang
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

Review 7.  Progesterone Actions and Resistance in Gynecological Disorders.

Authors:  James A MacLean; Kanako Hayashi
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

8.  SEOM-GEICO clinical guidelines on endometrial cancer (2021).

Authors:  María Pilar Barretina-Ginesta; María Quindós; Jesús Damián Alarcón; Carmen Esteban; Lydia Gaba; César Gómez; José Alejandro Pérez Fidalgo; Ignacio Romero; Ana Santaballa; María Jesús Rubio-Pérez
Journal:  Clin Transl Oncol       Date:  2022-03-21       Impact factor: 3.405

Review 9.  Cytokeratin Expression Pattern in Human Endometrial Carcinomas and Lymph Nodes Micrometastasis: a Mini-review.

Authors:  Danuta Vasilevska; Vilius Rudaitis; Aneta Adamiak-Godlewska; Anna Semczuk-Sikora; Dorota Lewkowicz; Dominika Vasilevska; Andrzej Semczuk
Journal:  J Cancer       Date:  2022-03-14       Impact factor: 4.207

Review 10.  New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers.

Authors:  Jitka Holcakova; Martin Bartosik; Milan Anton; Lubos Minar; Jitka Hausnerova; Marketa Bednarikova; Vit Weinberger; Roman Hrstka
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.